Video
Author(s):
Luis A. Diaz, MD, head of the division of Solid Tumor Oncology at Memorial Sloan Kettering Cancer Center, discusses the responses seen with microsatellite-instability high (MSI-H) and NTRK fusions in patients with gastrointestinal cancer.
Luis A. Diaz, MD, head of the division of Solid Tumor Oncology at Memorial Sloan Kettering Cancer Center, discusses the responses seen with microsatellite-instability high (MSI-H) and NTRK fusions in patients with gastrointestinal cancer.
MSI and NTRK fusions are present at a low level in multiple different tumor types. If found, the patient has dramatic responses that may be experienced for years, explains Diaz.
Further long-term research is needed to determine if these patients will achieve long-term survival or if they will progress, says Diaz.